Related Experiment Video
Updated: May 5, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management
Hannah L King1, Thalia Padilla-Lazos2, Akshit Chitkara3
1Department of Medicine, Oregon Health & Science University, Portland, OR, USA. kingh@ohsu.edu.
Insights
Catheter-related deep venous thrombosis (CR-DVT) management remains undefined. This review examines CR-DVT, advocating for individualized prophylaxis and treatment strategies, and calls for large trials to guide optimal care.
Area of Science:
- Vascular Medicine
- Thrombosis Research
- Clinical Guidelines
Background:
- Catheter-related deep venous thrombosis (CR-DVT) is a frequent complication of central venous catheters.
- Current prophylactic and treatment strategies for CR-DVT lack definitive evidence and standardized guidelines.
Purpose of the Study:
- To review the epidemiology, risk factors, and current management strategies for CR-DVT.
- To discuss diagnostic, prophylactic, and treatment options, including novel anticoagulants.
- To propose an individualized approach to CR-DVT prevention and management.
Main Methods:
- Comprehensive literature review of CR-DVT, including observational studies and randomized trials.
- Analysis of existing guideline recommendations for CR-DVT treatment.
- Exploration of future research directions and advances in anticoagulation.
Main Results:
- Data on CR-DVT prophylaxis and treatment are heterogeneous, often from small studies or extrapolated from lower extremity DVT trials.
- Guidelines suggest limited anticoagulation post-catheter removal or continuous anticoagulation if the catheter remains functional.
- A significant need exists for large, randomized controlled trials to establish optimal management, particularly for high-risk bleeding patients.
Conclusions:
- Optimal strategies for CR-DVT prevention and treatment require further definition through robust clinical trials.
- An individualized approach, considering patient-specific factors and bleeding risk, is crucial for current management.
- Novel anticoagulants may offer future therapeutic options for CR-DVT.
Abstract:
Catheter-related deep venous thrombosis (CR-DVT) is a common complication of central venous catheters, however optimal prophylactic and treatment strategies have yet to be fully defined. While the use of anticoagulation for CR-DVT prophylaxis is not routinely recommended, current available data offer heterogeneous results due to small sample size, non-uniform study design, and varying comorbid conditions. Available guidelines for the treatment of CR-DVT generally recommend a limited duration of anticoagulation after catheter removal. If ongoing use is required and the device remains functional, guidelines support anticoagulation throughout the time the catheter remains in place. It is worth acknowledging that data guiding these recommendations is largely derived from observational studies of upper extremity CR-DVT, along with randomized trials of anticoagulation in patients with lower extremity DVT. Therefore, large, randomized controlled trials are desperately needed to define optimal management, especially in patients who are at high risk for bleeding. This review explores the epidemiology and risk factors of CR-DVT, diagnostic, prophylactic and treatment strategies, guideline recommendations, and future advances in the field, including the introduction of novel anticoagulants. With current available evidence, we also conclude with an individualized approach to preventing and managing CR-DVT to assist clinicians who are faced with this common clinical scenario.
More Related Videos
Related Concept Videos
Cardiac Catheterization IV: Nursing Management
Atherosclerosis III: Management
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management

